Cholecystokinin receptors do not mediate the suppression of food-motivated behavior by lipopolysaccharide and interleukin-1 beta in mice

[1]  Akil,et al.  Evidence that Cholecystokinin Receptors are not Involved in the Hypothalamic‐Pituitary‐Adrenal Response to Intraperitoneal Administration of Interleukin‐1β , 1999, Journal of neuroendocrinology.

[2]  S. Maier,et al.  Interleukin-1β in Immune Cells of the Abdominal Vagus Nerve: a Link between the Immune and Nervous Systems? , 1999, The Journal of Neuroscience.

[3]  S. Maier,et al.  Bacterial Endotoxin Induces Fos Immunoreactivity in Primary Afferent Neurons of the Vagus Nerve , 1998, Neuroimmunomodulation.

[4]  Στυλιανή Τζιαφέρη,et al.  Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve , 1998, Brain Research.

[5]  R. Dantzer,et al.  Systemic Capsaicin Pretreatment Fails to Block the Decrease in Food-Motivated Behavior Induced by Lipopolysaccharide and Interleukin-1β , 1997, Brain Research Bulletin.

[6]  S. Maier,et al.  Vagal Paraganglia Bind Biotinylated Interleukin-1 Receptor Antagonist: A Possible Mechanism for Immune-to-Brain Communication , 1997, Brain Research Bulletin.

[7]  R. Dantzer,et al.  Cholecystokinin Receptors do not Mediate the Behavioral Effects of Lipopolysaccharide in Mice , 1997, Physiology & Behavior.

[8]  T. Lundeberg,et al.  Interleukin-1β sensitizes the response of the gastric vagal afferent to cholecystokinin in rat , 1997, Neuroscience Letters.

[9]  T. Lundeberg,et al.  Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats. , 1997, Journal of the autonomic nervous system.

[10]  R. Dantzer,et al.  Mechanisms of sickness-induced decreases in food-motivated behavior , 1996, Neuroscience & Biobehavioral Reviews.

[11]  A. Niijima,et al.  The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. , 1996, Journal of the autonomic nervous system.

[12]  R. Dantzer,et al.  Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. , 1996, Neuroreport.

[13]  R. Dantzer,et al.  Lipopolysaccharide and Interleukin-1 Depress Food-Motivated Behavior in Mice by a Vagal-Mediated Mechanism , 1995, Brain, Behavior, and Immunity.

[14]  S. Maier,et al.  Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids , 1994, Brain Research.

[15]  J. Walsh,et al.  Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats. , 1994, The American journal of physiology.

[16]  R. Dantzer,et al.  A behaviorally active dose of lipopolysaccharide increases sensory neuropeptides levels in mouse spinal cord , 1994, Neuroscience Letters.

[17]  W. Langhans,et al.  Does a learned taste aversion contribute to the anorectic effect of bacterial lipopolysaccharide? , 1993, Physiology & Behavior.

[18]  D. Farningham,et al.  Satiety signals in sheep: Involvement of CCK, propionate, and vagal CCK binding sites , 1993, Physiology & Behavior.

[19]  D. McCarthy,et al.  The role of cholecystokinin in interleukin-1-induced anorexia , 1993, Physiology & Behavior.

[20]  P. Ghezzi,et al.  Cytokine down-regulation in endotoxin tolerance. , 1993, European cytokine network.

[21]  R. Reidelberger.  Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats. , 1992, The American journal of physiology.

[22]  S. Matsukura,et al.  Stimulation of cholecystokinin (CCK) release from superfused rat hypothalamo-neurohypophyseal complexes by interleukin-1 (IL-1) , 1992, Brain Research.

[23]  J. Mercer,et al.  Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve , 1992, Neuroscience Letters.

[24]  C. Plata-salamán.  Immunoregulators in the nervous system , 1991, Neuroscience & Biobehavioral Reviews.

[25]  S. Cooper,et al.  Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding , 1990, Physiology & Behavior.

[26]  T. Shiraishi.  CCK as a central satiety factor: Behavioral and electrophysiological evidence , 1990, Physiology & Behavior.

[27]  R. J. Crosby,et al.  Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers , 1990, Brain Research.

[28]  Toshinori Mori,et al.  Actions of interferonα and interleukin-1β on the glucose-responsive neurons in the ventromedial hypothalamus , 1990, Brain Research Bulletin.

[29]  J. Lin,et al.  Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats. , 1990, The Journal of pharmacology and experimental therapeutics.

[30]  T. Yaksh,et al.  Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: A mapping study , 1990, Neuropharmacology.

[31]  S. Iversen,et al.  Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors. , 1989, European journal of pharmacology.

[32]  N. Mrosovsky,et al.  Anorexic effects of interleukin 1 in the rat. , 1989, The American journal of physiology.

[33]  N. Rothwell,et al.  Comparison of the effects of several endotoxin preparations on body temperature and metabolic rate in the rat. , 1989, Canadian journal of physiology and pharmacology.

[34]  R. Chang,et al.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. , 1989, European journal of pharmacology.

[35]  S. Zuckerman,et al.  Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis , 1989, European journal of immunology.

[36]  C. Plata-salamán,et al.  Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system , 1988, Brain Research.

[37]  H. Besedovsky,et al.  Interleukin 1 affects glucose homeostasis. , 1987, The American journal of physiology.

[38]  R. Pullen,et al.  Penetration of diazepam and the non‐peptide CCK antagonist, L‐364, 718, into rat brain , 1987, The Journal of pharmacy and pharmacology.

[39]  J. Morley,et al.  Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. , 1987, Science.

[40]  R. Chang,et al.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Crawley,et al.  Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin , 1985, Peptides.

[42]  J. A. Deutsch,et al.  An antiemetic is antidotal to the satiety effects of cholecystokinin , 1985, Nature.

[43]  A. Vander,et al.  The role of fever in appetite suppression after endotoxin administration. , 1984, The American journal of clinical nutrition.

[44]  M. Palkovits,et al.  Cholecystokinin in the nucleus of the solitary tract of the rat: evidence for its vagal origin , 1982, Brain Research.

[45]  G. P. Smith,et al.  Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.